That HIF-1 downregulates the antigen presenting MHC class I molecules is an important strategy for cancer to evade immune attack, because only in combination with MHC class I on the target cells, can tumor antigenic peptides be recognized by CD8+ CTL with the subsequent destruction of the target cells. The gene discussed is HIF1A; the disease is neoplasm.